Table 1.
C-CCA group | S-CCA group | P value | |
Incidence (%) | 10/211 (4.7) | 12/197 (6.1) | 0.546 |
Unilateral stones | 8/168 (4.8) | 7/156 (4.5) | 0.906 |
Bilateral stones | 2/43 (4.7) | 5/41 (12.2) | 0.211 |
Age, yr (range) | 61 (39-82) | 59 (46-69) | 0.742 |
Gender (%) | |||
Male | 1 (10) | 1 (8.3) | 0.892 |
Female | 9 (90) | 11 (91.7) | |
Mean interval from operation to CCA, mo (range) | - | 67 (7-138) | - |
Mean interval from CCA to disease-related death, mo (range) | 41 (3-107) | 4 (0-13) | 0.075 |
Follow-up time, mo (range) | 56 (2-140) | 71 (7-144) | 0.291 |
Mortality, n (%) | |||
Overall | 7 (70) | 12 (100) | 0.041 |
Disease-related | 6 (60) | 12 (100) | 0.015 |
C-CCA: Concomitant cholangiocarcinoma; S-CCA: Subsequent cholangiocarcinoma; CCA: Cholangiocarcinoma.